Search this site
Embedded Files
Skip to main content
Skip to navigation
www.reversade.com
Home
中文
بالعربية
en Français
en Español
auf Deutsch
به فارسی
Türkçe olarak
στα ελληνικα
हिंदी में
News & Views
Our People
Current Members
Emma SZENKER-RAVI
Former Members
Future Members
Graduate Students
Alumni
Principal Investigator
Work hard & Play hard
Projects
Publications
Conferences & Seminars
What's Cooking
by Themes
Ideas
Contact Us
www.reversade.com
Home
中文
بالعربية
en Français
en Español
auf Deutsch
به فارسی
Türkçe olarak
στα ελληνικα
हिंदी में
News & Views
Our People
Current Members
Emma SZENKER-RAVI
Former Members
Future Members
Graduate Students
Alumni
Principal Investigator
Work hard & Play hard
Projects
Publications
Conferences & Seminars
What's Cooking
by Themes
Ideas
Contact Us
More
Home
中文
بالعربية
en Français
en Español
auf Deutsch
به فارسی
Türkçe olarak
στα ελληνικα
हिंदी में
News & Views
Our People
Current Members
Emma SZENKER-RAVI
Former Members
Future Members
Graduate Students
Alumni
Principal Investigator
Work hard & Play hard
Projects
Publications
Conferences & Seminars
What's Cooking
by Themes
Ideas
Contact Us
Novel Peptides & Their Receptors
The ELABELA-ergic pathway
202?
ELABELA's second cognate receptor
2017
ELABELA inactivation brings about Pre-eclampsia
2017
ELABELA's role in coronary development
2015
ELABELA guards pluripotency of human embryonic stem cells
2013
The discovery of a new hormone: ELABELA and its Recepto
r
The RETO-ergic pathway
202
-
Oncology indications
2022
A novel circulating hormone RETO that blocks CCR7 signalling
A novel GABA-ergic peptide
202-
A lncRNA produces a small peptide with affinity to GABA receptors
Interested in joining? Contact
bruno(at)reversade(dot)com
for more information.
Report abuse
Page details
Page updated
Report abuse